Alzheimer's Disease Trial, By Invitation NCT05999084 Sponsor: Emory University Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, By Invitation

NCT05999084
By Invitation Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 50 and 90 years old (inclusive)
  • You have been diagnosed with Mild Cognitive Impairment (MCI) or mild Alzheimer's dementia, confirmed by a spinal fluid test or a special brain scan that detects amyloid protein
  • You have had recent cognitive (thinking and memory) tests within the past 3 months showing scores above certain levels, and you are still able to take care of your basic daily needs independently
  • You have had a brain MRI scan within the last year with no findings that would prevent you from joining
  • You have had recent blood tests (checking things like blood cell counts, kidney and liver function, vitamins, thyroid, and clotting) with no serious abnormalities
  • A family member, caregiver, or close contact is available to attend follow-up visits to give information about how you are thinking and functioning day-to-day
  • You agree to undergo MRI scans, PET scans, other required tests, and a genetic test (checking your APOE gene) to help determine whether specific treatments are appropriate for you

Who may not be able to join:

  • You have any reason you cannot safely have an MRI scan (confirm with trial site)
  • Your MRI shows certain types of bleeding in the brain, more than 4 tiny bleeds, a known brain aneurysm, or other findings that could be dangerous or explain your symptoms
  • You have had a seizure in the past 6 months, or you have a history of epilepsy that has been difficult to control
  • You have had a serious, unstable mental health condition in the past 6 months
  • You have a history of a bleeding or clotting disorder, or your blood clotting test results are outside safe limits
  • Your diabetes is not well controlled (confirm with trial site)
  • Your blood pressure is not well controlled
  • You have had unstable chest pain, a heart attack, advanced heart failure, or a serious heart rhythm problem within the past year
  • You have end-stage kidney disease
  • You are currently receiving active cancer treatment such as chemotherapy or radiation (though some maintenance therapies for cancer in remission may be allowed — confirm with trial site)
  • You have had a serious illness or infection such as pneumonia, sepsis, or COVID-19 in the past 30 days
  • You have an immune system disease requiring certain treatments such as immunosuppressants or plasma exchange (confirm with trial site)
  • You are breastfeeding, or you are a woman who could become pregnant and are unable to use highly effective contraception
  • You have a history of severe allergic reactions, or you are known to be allergic to certain ingredients used in the study drug (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 March 2025
Est. completion
1 July 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Quick Dementia Rating System (QDRS) Score; Montreal Cognitive Assessment (MoCA) Score; Change in Functional Activities Questionnaire (FAQ) Score; Change in Lawton-Brody Activities of Daily Living (ADL) Physical Self-Maintenance Scale (PSMS) Score; Change in Lawton-Brody Instrumental Activities of Daily Living (IADL) Scale Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov